Menora Mivtachim Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150M | Hold |
304,632
| – | – | 0.71% | 41 |
|
|
2025
Q4 | $177M | Hold |
304,632
| – | – | 0.83% | 38 |
|
|
2025
Q3 | $148M | Buy |
304,632
+132,700
| +77% | +$61.8M | 0.75% | 37 |
|
|
2025
Q2 | $69.7M | Hold |
171,932
| – | – | 0.4% | 63 |
|
|
2025
Q1 | $85.6M | Sell |
171,932
-47,379
| -22% | -$25.7M | 0.55% | 56 |
|
|
2024
Q4 | $114M | Sell |
219,311
-165,336
| -43% | -$90.9M | 0.72% | 45 |
|
|
2024
Q3 | $238M | Sell |
384,647
-87,459
| -19% | -$51.8M | 1.5% | 24 |
|
|
2024
Q2 | $261M | Buy |
472,106
+4,760
| +1% | +$2.73M | 1.77% | 18 |
|
|
2024
Q1 | $272M | Buy |
467,346
+43,457
| +10% | +$24.4M | 2.04% | 17 |
|
|
2023
Q4 | $225M | Hold |
423,889
| – | – | 1.89% | 16 |
|
|
2023
Q3 | $215M | Buy |
423,889
+3,404
| +0.8% | +$1.81M | 1.95% | 17 |
|
|
2023
Q2 | $219M | Buy |
420,485
+67,300
| +19% | +$36.3M | 2.03% | 14 |
|
|
2023
Q1 | $204M | Sell |
353,185
-33,010
| -9% | -$18.6M | 2.1% | 15 |
|
|
2022
Q4 | $213M | Buy |
386,195
+73,100
| +23% | +$38.7M | 3.58% | 7 |
|
|
2022
Q3 | $159M | Buy |
313,095
+18,400
| +6% | +$10.3M | 3% | 8 |
|
|
2022
Q2 | $160M | Hold |
294,695
| – | – | 2.92% | 9 |
|
|
2022
Q1 | $174M | Hold |
294,695
| – | – | 2.52% | 13 |
|
|
2021
Q4 | $197M | Sell |
294,695
-59,500
| -17% | -$37.1M | 2.67% | 9 |
|
|
2021
Q3 | $202M | Hold |
354,195
| – | – | 2.96% | 8 |
|
|
2021
Q2 | $179M | Hold |
354,195
| – | – | 2.57% | 13 |
|
|
2021
Q1 | $162M | Hold |
354,195
| – | – | 2.65% | 13 |
|
|
2020
Q4 | $165M | Buy |
354,195
+80,500
| +29% | +$37.7M | 2.88% | 10 |
|
|
2020
Q3 | $121M | Sell |
273,695
-3,510
| -1% | -$1.45M | 2.69% | 12 |
|
|
2020
Q2 | $100M | Hold |
277,205
| – | – | 2.46% | 16 |
|
|
2020
Q1 | $78.6M | Buy |
277,205
+86,900
| +46% | +$27.4M | 2.14% | 21 |
|
|
2019
Q4 | $61.8M | Sell |
190,305
-137,900
| -42% | -$41.8M | 1.47% | 39 |
|
|
2019
Q3 | $95.6M | Buy |
328,205
+2,300
| +0.7% | +$659K | 2.32% | 14 |
|
|
2019
Q2 | $95.7M | Hold |
325,905
| – | – | 2.59% | 12 |
|
|
2019
Q1 | $89.2M | Hold |
325,905
| – | – | 2.4% | 10 |
|
|
2018
Q4 | $72.9M | Buy |
325,905
+63,600
| +24% | +$14.9M | 2.11% | 13 |
|
|
2018
Q3 | $64M | Hold |
262,305
| – | – | 1.73% | 14 |
|
|
2018
Q2 | $54.3M | Buy |
262,305
+81,000
| +45% | +$17.2M | 1.54% | 14 |
|
|
2018
Q1 | $37.4M | Buy |
181,305
+60,000
| +49% | +$12.6M | 1.19% | 26 |
|
|
2017
Q4 | $23M | Hold |
121,305
| – | – | 0.89% | 47 |
|
|
2017
Q3 | $23M | Buy |
+121,305
| New | +$22M | 0.93% | 43 |
|
Other funds holding TMO
VCM
Menora Mivtachim Holdings's TMO Position: Q1 2026 in Review
Menora Mivtachim Holdings held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 304,632 shares worth $150M. The position accounts for 0.71% of the portfolio, ranked #41.
Menora Mivtachim Holdings first reported a position in TMO in Q3 2017 and has held it in 35 quarters since. The position peaked at $272M in Q1 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Menora Mivtachim Holdings held 304,632 shares of Thermo Fisher Scientific worth $150M as of Q1 2026.
- Menora Mivtachim Holdings left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.71% of Menora Mivtachim Holdings's portfolio in Q1 2026, its #41 holding.
- Menora Mivtachim Holdings first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 35 quarters since.
- Menora Mivtachim Holdings's Thermo Fisher Scientific position peaked at $272M in Q1 2024.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Menora Mivtachim Holdings's 13F filing for Q1 2026, filed 14 May 2026.